Partner Headlines - LLY

  1. Lilly Issues Update on Evacetrapib Phase 3 Trial: Last Patient ...

    Benzinga
  2. Biogen's Big-Volume Plunge Marks End Of 5-Year Run

    IBD
  3. Valeant Posts Princely Gains

    IBD
  4. 3 Big-Cap Drugmakers Who Beat Q2 Earnings Estimates

    IBD
  5. Shire Lifts 2015 Guidance On Strong Drug Pipeline

    IBD
  6. Lilly, Bristol-Myers Beat Q2 Views, Lift Guidance

    IBD
  7. Valeant Earnings Soar On M&A, Organic Sales Growth

    IBD
  8. Wall Street Struggles for Direction After Two-Day Selloff

    FoxBusiness
  9. Alzheimer's Data Diverge

    IBD
  10. Biogen, Lilly Alzheimer's Data Spark Street Debate

    IBD
  11. Are We Any Closer to Finding a Drug to Battle Alzheimer's?

    FoxBusiness
  12. Data Using New Delayed-Start Methodology Suggested Benefit of ...

    Benzinga
  13. Fast Money Picks For July 21

    Benzinga
  14. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD
  15. Celgene Hits High As Street Applauds Receptos Buyout

    IBD
  16. Manning & Napier Advisors' Most Weighted Trades in Q2 2015

    GuruFocus
  17. Weekly 52-Week Highs Highlight: LLY, PLL, SBUX, VLO

    GuruFocus
  18. Eli Lilly Shares Go Parabolic

    Benzinga
  19. Stocks Cling To Thin Early Gains; Ambarella Bounces, Cree Dives

    IBD
  20. Alder Bio Up As Credit Suisse Lauds Migraine Drug

    IBD
  21. Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The ...

    GuruFocus
  22. Where Can Mega-Drug Stock Gilead Sciences Go Now?

    IBD
  23. Teva Migraine Drug Succeeds In Midstage Trial

    IBD
  24. Teva Migraine Drug Succeeds In Midstage Trial

    IBD
  25. Benzinga's Top Initiations

    Benzinga
  26. Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks

    GuruFocus
  27. New Migraine Drugs Could Ease Investors' Headaches

    IBD
  28. What We Don't Know About Antibiotics Could Kill Us

    FoxBusiness
  29. ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO

    IBD
  30. 4 Stocks Rising On ASCO Cancer Drug News

    IBD
  31. Bristol Sinks On Lung Cancer Data; Merck Up On 2 Trials

    IBD
  32. Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase ...

    Benzinga
  33. Lilly to Present New Clinical Data at 75th American Diabetes ...

    Benzinga
  34. Amgen Down After Suicides Kill AstraZeneca Deal

    IBD
  35. IPO Stock Watch: Alder Soars On Migraine Drug Results

    IBD
  36. Vanguard Adds to Four of Its Largest Stakes

    GuruFocus
  37. Biogen Making A Breakthrough In Treating Alzheimer's

    GuruFocus
  38. 8 Dividend Stocks With The Right Qualities

    GuruFocus
  39. MannKind Looks Good For Long Term Investors

    GuruFocus
  40. Citigroup Upgrades Eli Lilly To Buy

    Benzinga
  41. Novartis EPS beats the Street

    IBD
  42. Eli Lilly

    IBD
  43. US Stock Futures Down Ahead Of Earnings, Economic Data

    Benzinga
  44. Eli Lilly Tops Q1 Views

    Benzinga
  45. Eli Lilly Partner Deciphera Pharma Announces Data Highlighting ...

    Benzinga
  46. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD
  47. 5 'Key Pipeline Catalysts' To Watch At Eli Lilly

    Benzinga
  48. Can Veeva Systems' Software Keep Luring Big Pharma?

    IBD
  49. IPO Alert: Biotech Investors Should Watch Advanced Accelerator's ...

    Benzinga
  50. UBS: Eli Lilly's 'Outlook Continuing To Improve'

    Benzinga
  51. Eli Lilly CEO Explains The Reasons Behind Not Changing 2015 Guidance ...

    Benzinga
  52. Viekira Pak View Falls Short

    IBD
  53. AbbVie Beats, But Stock Falls; Lilly Cuts Guidance

    IBD
  54. UPDATE: Eli Lilly Posts Upbeat Q4 Profit, Sales Decline

    Benzinga
  55. Earnings Scheduled For January 30, 2015

    Benzinga
  56. 10 Must Watch Stocks for Today

    Benzinga
  57. Box Ready To Unwrap IPO In Hot Online Storage Field

    IBD
  58. Feeling Good With This Med Company

    GuruFocus
  59. Eli Lilly

    IBD
  60. Here Is Goldman Sachs' Potential Pair Trade For 2 Drug Giants

    Benzinga
  61. 10 Biotech Stories You Might've Missed This Week

    Benzinga
  62. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD
  63. Exclusive: JPMorgan Chase CEO Jamie Dimon Talks Cancer Recovery, ...

    FoxBusiness
  64. Eil Lilly CEO Talks New Product Launches, Pricing Pressure From ...

    Benzinga
  65. FDA Issues Import Block On Eli Lilly's Cialis

    Benzinga
  66. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  67. Deutsche Bank, Stifel Differ On Outlook For Eli Lilly

    Benzinga
  68. Benzinga's Top Upgrades

    Benzinga
  69. Jefferies Upgrades Eli Lilly To Buy

    Benzinga
  70. UPDATE: Deutsche Bank Downgrades Eli Lilly On Positive Outlook, ...

    Benzinga
  71. Eli Lilly

    IBD
  72. Alkermes Hits High On Schizophrenia Drug Results

    IBD
  73. Eli Lilly Moves Higher Following FY 2014 & 2015 Outlook

    Benzinga
  74. Benzinga's Top #PreMarket Losers

    Benzinga
  75. Fast Money Halftime Report Final Trade From January 6

    Benzinga
  76. US Stock Futures Surge Ahead Of Manufacturing Data

    Benzinga
  77. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD
  78. 7 Stocks You Should Be Watching Today

    Benzinga
  79. Eli Lilly

    IBD
  80. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD
  81. Alexandria Real Estate REIT Inks Rx For Pharma Boom

    IBD
  82. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD
  83. Zosano Pharma and Eli Lilly and Company Enter Into Exclusive ...

    Benzinga
  84. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD
  85. Screening Pharma Stocks Amid Turnaround

    YCharts
  86. Sarah Ketterer Dives in when Others Pull Out

    GuruFocus
  87. Credit Suisse Raises Eli Lilly Price Target

    Benzinga
  88. Veeva Systems Flies High On Cloud For Life Sciences

    IBD
  89. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD
  90. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD
  91. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  92. Earnings Scheduled For October 23, 2014

    Benzinga
  93. CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

    Benzinga
  94. Lilly, Zymeworks Announce Expansion Of Strategic Licensing And ...

    Benzinga
  95. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  96. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  97. UPDATE: Lilly To Initiate Efforts To Sell Guayama Site

    Benzinga
  98. Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

    Benzinga
  99. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD
  100. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!